| III-15 Guillaume Baneyx Target-mediated drug disposition modeling of lacnotuzumab in healthy volunteers and patients with advanced malignancies and triple negative breast cancer. Thursday 09:55-11:30 |
| III-15 Guillaume Baneyx Target-mediated drug disposition modeling of lacnotuzumab in healthy volunteers and patients with advanced malignancies and triple negative breast cancer. Thursday 09:55-11:30 |